Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Júlia Taddeo"'
Autor:
Mônica Rika Nakamura, Lúcio R. Requião-Moura, Roberto Mayer Gallo, Camila Botelho, Júlia Taddeo, Laila Almeida Viana, Cláudia Rosso Felipe, José Medina-Pestana, Hélio Tedesco-Silva
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Due to the high costs, the strategy to reduce the impact of cytomegalovirus (CMV) after kidney transplant (KT) involves preemptive treatment in low and middle-income countries. Thus, this retrospective cohort study compared the performance o
Externí odkaz:
https://doaj.org/article/7378d8a470be4f69a81dd11431431a8e
Autor:
Mônica Rika Nakamura, Lúcio R. Requião-Moura, Roberto Mayer Gallo, Camila Botelho, Júlia Taddeo, Laila Almeida Viana, Cláudia Rosso Felipe, José Medina-Pestana, Hélio Tedesco-Silva
Due to the high costs, the strategy to reduce the impact of cytomegalovirus (CMV) after kidney transplant (KT) involves preemptive treatment in low and middle-income countries. Thus, this retrospective cohort study compared the performance of antigen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5914b427f0aab8452cfcafde4ed6c17
https://doi.org/10.21203/rs.3.rs-1168330/v1
https://doi.org/10.21203/rs.3.rs-1168330/v1
Autor:
Mônica Rika Nakamura, Lúcio R. Requião-Moura, Roberto Mayer Gallo, Camila Botelho, Júlia Taddeo, Laila Almeida Viana, Cláudia Rosso Felipe, José Medina-Pestana, Hélio Tedesco-Silva
Publikováno v:
Scientific reports. 12(1)
Due to the high costs, the strategy to reduce the impact of cytomegalovirus (CMV) after kidney transplant (KT) involves preemptive treatment in low and middle-income countries. Thus, this retrospective cohort study compared the performance of antigen
Autor:
Melissa Gaspar Tavares, Marina Pontello Cristelli, Julia Taddeo, Helio Tedesco Silva Junior, Jose Medina Pestana
Publikováno v:
Brazilian Journal of Nephrology (2022)
ABSTRACT Background: Early hospital readmission (EHR) is associated with worse outcomes. The use of anti-thymocyte globulin (rATG) induction therapy is associated with increased efficacy in preventing acute rejection, although safety concerns still e
Externí odkaz:
https://doaj.org/article/32567f67e29a4c89a821f73c226282a3